You just read:

EU Rheumatoid Arthritis Landscape Poised for Big Changes as Rheumatologists Plan for the Adoption of Eli Lilly/Incyte's Olumiant, Pfizer's Xeljanz, and Regeneron/Sanofi's Kevzara

News provided by

Spherix Global Insights

May 04, 2017, 12:10 ET